أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - docetaxel -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - head and neck cancer, small cell lung cancer, testicular cancer, ovarian cancer, uterine cancer, malignant lymphoma, non-small cell lung cancer, breast cancer used in conjunction with other antineoplastic drugs for the following malignant tumours: paediatric solid malignant tumours (neuroblastoma/retinoblastoma/ hepatoblastoma/central nervous system neuroblastoma, recurrent or refractory ewing?s sarcoma family tumours/nephroblastoma)

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - head and neck cancer, small cell lung cancer, testicular cancer, ovarian cancer, uterine cancer, malignant lymphoma, non-small cell lung cancer, breast cancer used in conjunction with other antineoplastic drugs for the following malignant tumours: paediatric solid malignant tumours (neuroblastoma/retinoblastoma/ hepatoblastoma/central nervous system neuroblastoma, recurrent or refractory ewing?s sarcoma family tumours/nephroblastoma)

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - head and neck cancer, small cell lung cancer, testicular cancer, ovarian cancer, uterine cancer, malignant lymphoma, non-small cell lung cancer, breast cancer used in conjunction with other antineoplastic drugs for the following malignant tumours: paediatric solid malignant tumours (neuroblastoma/retinoblastoma/ hepatoblastoma/central nervous system neuroblastoma, recurrent or refractory ewing?s sarcoma family tumours/nephroblastoma)

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - 1. relief of subjective and objective symptoms in the following diseases: acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: breast cancer (pre- and post-operative chemotherapy in operable cases)

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - 1. relief of subjective and objective symptoms in the following diseases: acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: breast cancer (pre- and post-operative chemotherapy in operable cases)

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - oxaliplatin, quantity: 5 mg/ml - injection, intravenous infusion - excipient ingredients: tartaric acid; sodium hydroxide; water for injections - oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin, is indicated for: * adjuvant treatment of stage iii colon cancer in patients who have undergone complete resection of the primary tumor. * treatment of advanced colorectal cancer.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - oxaliplatin, quantity: 5 mg/ml - injection, intravenous infusion - excipient ingredients: tartaric acid; sodium hydroxide; water for injections - oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin is indicated for: * adjuvant treatment of stage iii colon cancer in patients who have undergone complete resection of the primary tumour * treatment of advanced colorectal cancer.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: lactic acid; sorbitol; water for injections - small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non hodgkin's disease).

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: lactic acid; sorbitol; water for injections - small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non hodgkin's disease).